Diagnostic and Interventional Cardiology

First FDA approved transcatheter therapy for patients with tricuspid regurgitation

Atlantic Health System’s Morristown Medical Center Treats First Patient in New Jersey with Edwards’ EVOQUE Tricuspid Valve Replacement

April 25, 2024 — Atlantic Health System’s Morristown Medical Center treated the first patient in New Jersey using ...

April 25, 2024

Patent covers use of AI-ECG for any echo measure of diastolic function, which is crucial for heart screening and early detection of heart disease

News | Artificial Intelligence

HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG

April 24, 2024 — Heart Test Laboratories, Inc. d/b/a HeartSciences, an artificial intelligence (AI)-powered medical ...

April 24, 2024

News | FDA

Innovative Aspiration Thrombectomy System by Expanse ICE Receives FDA Clearance for Vessels of the Peripheral Arterial and Venous Systems

April 24, 2024 — Expanse ICE announced today the ICE Aspiration System has received 510(k) clearance from the U.S. Food ...

April 24, 2024

Sponsored Content

Feature | Nuclear Imaging

Cardiac PET/CT — A New Standard for Cardiac Imaging

Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...

November 12, 2025

New study shows an overwhelming majority of people aged 65 and over reduced their blood pressure, cholesterol, and weight while using the Hello Heart mobile app and heart health monitor within six months

News | Cardiovascular Clinical Studies

New Study Reveals 65 and Older Population Lowered Blood Pressure, Cholesterol and Weight Using Mobile Technology

April 24, 2024 —Hello Heart, a digital leader in preventive heart health, today announced results from its latest study ...

April 24, 2024

CDL now offers three solutions for cardiovascular imaging needs

News | Cardiac Imaging

CDL Nuclear Technologies Launches New Mobile Cardiac PET/CT Trailer

April 23, 2024 — CDL Nuclear Technologies, a pioneer in advanced diagnostic solutions, is proud to announce the launch ...

April 23, 2024

Using two primary markers‑— coronary calcium and heart chamber size — A routine chest scan without contrast shows promise for disease detection

News | Artificial Intelligence

Artificial Intelligence Can Evaluate Cardiovascular Risk During CT Scan

April 23, 2024 — A recent study designed and implemented by investigators at Cedars-Sinai found that artificial ...

April 23, 2024

Sponsored Content

Feature

Intuitive Imaging Workflow System Offers Improved Efficiency, Flexibility

SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...

June 17, 2025

Next-generation Avalus Ultra valve is Medtronic’s most advanced surgical aortic tissue valve built on 10 years of clinical experience with the Avalus valve

News | Cardiovascular Surgery

Medtronic Launches the Avalus Ultra Valve Engineered for Ease of Use at Implant and Lifetime Patient Management

April 23, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest ...

April 23, 2024

A new study showed that a non-invasive imaging test can help identify patients with coronary artery blockage or narrowing who need a revascularization procedure

News | Computed Tomography (CT)

Novel CT Exam Reduces Need for Invasive Artery Treatment

April 22, 2024 — A new study showed that a non-invasive imaging test can help identify patients with coronary artery ...

April 22, 2024

RCE Technologies, Inc. (RCE) is an innovative artificial intelligence (AI) based medical technology company dedicated to early heart attack detection.

News | FDA

RCE Technologies, Inc. Announces First-In-Human Transdermal Continuous Cardiac Biomarker Monitoring

April 22, 2024 — At the annual American College of Cardiology conference (ACC.24) in Atlanta last week, RCE Technologies ...

April 22, 2024

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

Second major trial for atrial shunt therapy demonstrates importance of patient selection

News | Cardiovascular Clinical Studies

Corvia's RESPONDER-HF Confirmatory Trial Supported by RELIEVE-HF Data

April 22, 2024 — Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, welcomes the ...

April 22, 2024

New evidence published in Heart Rhythm underpins why the blanking period should be shortened

News | Atrial Fibrillation

Shorten the Blanking Period After Atrial Fibrillation Ablation, Experts Say

April 18, 2024 — New evidence-based research calls into question the conventional three-month blanking period ...

April 18, 2024

AI-enriched platform transforms disparate data into actionable insights for care providers and partners, boosts patient engagement and access to care for improved outcomes at lower cost

News | Artificial Intelligence

Karoo Health Launches Proprietary Technology Platform Kohere.ai to Supercharge Its Cardiac Value-based Care Model

April 18, 2024 — Karoo Health, the only operational provider of cardiac value-based care (VBC) enablement with published ...

April 18, 2024

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

AB-1002 is being studied for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) Class III heart failure symptoms

News | FDA

AskBio Receives FDA Fast Track Designation for AB-1002 Investigational Gene Therapy Program in Congestive Heart Failure

April 18, 2024 — Bayer AG and Asklepios BioPharmaceutical, Inc., a gene therapy company wholly owned and independently ...

April 18, 2024

Getinge and Cook Medical announced an exclusive sales and distribution agreement for the iCast covered stent system, which has been on the market for twenty years and recently received premarket approval for treatment of iliac arterial occlusive disease

News | Stents

Getinge Enters into Commercial Distribution Agreement with Cook Medical for iCast Covered Stent System in the United States

April 17, 2024 — Getinge and Cook Medical announced an exclusive sales and distribution agreement for the iCast covered ...

April 17, 2024

News | Heart Valve Technology

CPR-Therapeutics, Inc. Names Mike Black as Chief Strategy Officer

April 17, 2024 —CPR Therapeutics, Inc. (CPR-T), an early-stage medtech startup funded by the N.I.H and N.S.F to develop ...

April 17, 2024